Total Payments
$164,840
2024 Payments
$31,059
Companies
48
Transactions
1,047
Medicare Patients
3,563
Medicare Billing
$317,120
Payment Breakdown by Category
Other$106,325 (64.5%)
Food & Beverage$22,971 (13.9%)
Consulting$20,280 (12.3%)
Travel$13,693 (8.3%)
Research$1,000 (0.6%)
Education$570.70 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $106,325 | 41 | 64.5% |
| Food and Beverage | $22,971 | 931 | 13.9% |
| Consulting Fee | $20,280 | 12 | 12.3% |
| Travel and Lodging | $13,693 | 41 | 8.3% |
| Unspecified | $1,000 | 8 | 0.6% |
| Education | $570.70 | 14 | 0.3% |
Payments by Type
General
$163,840
1,039 transactions
Research
$1,000
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $70,272 | 175 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $25,761 | 58 | $0 (2024) |
| Abbott Laboratories | $19,930 | 157 | $0 (2024) |
| PFIZER INC. | $14,687 | 67 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $9,499 | 90 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $7,467 | 112 | $0 (2024) |
| Lilly USA, LLC | $4,433 | 2 | $0 (2024) |
| ABIOMED | $2,258 | 38 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,886 | 19 | $0 (2024) |
| United Therapeutics Corporation | $1,317 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,059 | 178 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,444) |
| 2023 | $31,596 | 169 | Alnylam Pharmaceuticals Inc. ($21,566) |
| 2022 | $4,863 | 133 | Alnylam Pharmaceuticals Inc. ($1,361) |
| 2021 | $3,936 | 118 | Bayer HealthCare Pharmaceuticals Inc. ($1,454) |
| 2020 | $2,047 | 75 | PFIZER INC. ($744.07) |
| 2019 | $20,833 | 144 | Novartis Pharmaceuticals Corporation ($13,134) |
| 2018 | $23,703 | 110 | Novartis Pharmaceuticals Corporation ($20,477) |
| 2017 | $46,804 | 120 | Novartis Pharmaceuticals Corporation ($35,834) |
All Payment Transactions
1,047 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $9.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/24/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | BrioHealth Solutions, Inc. | BRIOVAD (Device) | Food and Beverage | In-kind items and services | $77.03 | General |
| Category: DURABLE MECHANICAL CIRCULATORY SUPPORT SYSTEM | ||||||
| 12/18/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $840.00 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | United Therapeutics Corporation | REMODULIN (Drug), ORENITRAM | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Medtronic, Inc. | VITALFLOW CONSOLE (Device) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Cardiopulmonary | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: Cardiovascular | ||||||
| 12/03/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Cardiology | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: Cardiology | ||||||
| 11/27/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Heart Failure | ||||||
| 11/25/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Genetic Disease | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.57 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $120.09 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: Heart Failure | ||||||
| 11/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Cardiology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of Sotagliflozin on Clinical Outcomes in Hemodynamically Stable Patients With Type 2 Diabetes | SANOFI US SERVICES INC. | $1,000 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 910 | 1,811 | $325,699 | $95,948 |
| 2022 | 16 | 846 | 1,267 | $202,279 | $57,854 |
| 2021 | 19 | 954 | 1,563 | $232,933 | $85,145 |
| 2020 | 18 | 853 | 1,353 | $211,608 | $78,172 |
Total Patients
3,563
Total Services
5,994
Medicare Billing
$317,120
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 40 | 198 | $84,150 | $30,820 | 36.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 77 | 245 | $26,460 | $14,172 | 53.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 52 | 150 | $23,100 | $13,064 | 56.6% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 67 | 269 | $36,590 | $7,558 | 20.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 86 | 113 | $26,120 | $5,073 | 19.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 48 | $9,792 | $4,479 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 75 | 89 | $12,371 | $3,860 | 31.2% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 40 | 49 | $18,573 | $3,754 | 20.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 81 | 155 | $31,765 | $2,781 | 8.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 25 | 30 | $5,880 | $2,071 | 35.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 23 | $3,657 | $1,923 | 52.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 32 | 55 | $3,245 | $1,922 | 59.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 64 | 75 | $6,525 | $1,719 | 26.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 25 | 27 | $3,159 | $1,592 | 50.4% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 75 | 123 | $10,507 | $624.75 | 5.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 75 | 122 | $21,804 | $272.58 | 1.3% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 19 | 19 | $1,539 | $143.65 | 9.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 19 | 21 | $462.00 | $120.20 | 26.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 30 | 66 | $26,972 | $10,263 | 38.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 71 | 156 | $16,670 | $7,940 | 47.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 119 | 145 | $35,338 | $7,133 | 20.2% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 60 | 65 | $21,963 | $5,408 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 75 | 102 | $14,122 | $4,476 | 31.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 29 | $8,622 | $4,236 | 49.1% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 54 | 132 | $17,952 | $3,724 | 20.7% |
About Dr. Patrick Campbell, MD
Dr. Patrick Campbell, MD is a Internal Medicine healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1215113154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Campbell, MD has received a total of $164,840 in payments from pharmaceutical and medical device companies, with $31,059 received in 2024. These payments were reported across 1,047 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($106,325).
As a Medicare-enrolled provider, Campbell has provided services to 3,563 Medicare beneficiaries, totaling 5,994 services with total Medicare billing of $317,120. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Hypertension Specialist
- Location Little Rock, AR
- Active Since 01/10/2008
- Last Updated 11/22/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215113154
Products in Payments
- ENTRESTO (Drug) $69,959
- AMVUTTRA (Drug) $18,626
- VYNDAQEL (Drug) $14,403
- JARDIANCE (Drug) $13,891
- Circulatory Support (Device) $10,204
- ONPATTRO (Drug) $7,135
- UPTRAVI (Drug) $6,238
- HeartMate 3 Left Ventricular Dev (Device) $4,434
- Impella (Device) $2,258
- Adempas (Drug) $1,695
- CARDIOMEMS (Device) $1,283
- CardioMEMS HF System (Device) $1,171
- OPSUMIT (Drug) $1,040
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $1,022
- SAR439954 (Drug) $1,000
- HeartMate II LVAS (Device) $853.39
- FARXIGA (Drug) $633.72
- TYVASO (Drug) $595.84
- LifeVest (Device) $491.83
- VERQUVO (Drug) $437.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Little Rock
Jorge Saucedo, Md, MD
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Gaurav Dhar, Md, MD
Internal Medicine — Payments: $169,860
Internal Medicine $169,860
Muthu Kumaran, M.d, M.D
Internal Medicine — Payments: $151,498
Internal Medicine $151,498
John Mounsey, M.d, M.D
Internal Medicine — Payments: $136,906
Internal Medicine $136,906
Luis Juncos, M.d, M.D
Internal Medicine — Payments: $94,880
Internal Medicine $94,880
Dr. Wesley Lane, M.d, M.D
Internal Medicine — Payments: $47,683
Internal Medicine $47,683